Dr. Krishna Prasad Kolandaivel, MD

Dr. Kolandaivel practices at Aspirus St. Luke's Hospital in Duluth, Minnesota, part of Aspirus.

Dr. Kolandaivel's NPI, 1255675492, was assigned on November 10, 2012. Dr. Kolandaivel holds Minnesota license 63110.

Dr. Kolandaivel's primary practice is Aspirus St. Luke's Hospital, at 915 East 1st Street, Duluth, MN 55805 in St. Louis County. The practice phone is (218) 249-5555.

Dr. Kolandaivel's primary practice is Aspirus St. Luke's Hospital in Duluth, Minnesota, part of Aspirus. Dr. Kolandaivel is also affiliated with Aspirus Wausau Hospital. The medical group on file is Aspirus St. Luke's Hospital. Dmand AI also links Dr. Kolandaivel to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kolandaivel practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kolandaivel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kolandaivel is licensed in Minnesota.

CMS data shows 342 Medicare services from Dr. Kolandaivel across 5 procedure codes in 2024, all of them office visits, for 150 Medicare patients. Medicare paid $24,422 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 150 Medicare patients who saw Dr. Kolandaivel in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kolandaivel's median patient age at 74, with 54% women.

In 2024, Dr. Kolandaivel wrote 1,663 Medicare Part D claims for 268 patients. 80% of them were for generic drugs. CMS names the drug for 1,364 of them, across 35 drugs with 11 or more claims each, at $2,004,304 in total drug cost. In 2023, CMS named 1,086 claims across 27 drugs.

Dr. Kolandaivel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kolandaivel as offering telehealth.

Dmand AI links 2 papers to Dr. Kolandaivel in 2021. 2021 was the busiest year, with 2. Dr. Kolandaivel's most frequent co-authors are Kalaimani Elango, MD, Chowdhury H. Ahsan, MD and Arul Velavan Chandran, MD.

CMS Open Payments shows 7 general payments to Dr. Kolandaivel from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 55% of the total. Genentech, Inc. paid the most, $137.